Citadel Advisors
CELL

Citadel Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Citadel Advisors’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-67,104
Closed -$54.9K – 15579
2023
Q1 		$77.8K Sell
67,104
-13,967
-17% -$25.5K ﹤0.01% 11599
2022
Q4 		$217K Sell
81,071
-165,406
-67% -$436K ﹤0.01% 9971
2022
Q3 		$705K Buy
246,477
+197,323
+401% +$839K ﹤0.01% 7732
2022
Q2 		$244K Sell
49,154
-88,354
-64% -$463K ﹤0.01% 10276
2022
Q1 		$978K Sell
137,508
-274,234
-67% -$2.27M ﹤0.01% 7744
2021
Q4 		$7.49M Sell
411,742
-44,916
-10% -$969K ﹤0.01% 3588
2021
Q3 		$8.93M Buy
456,658
+407,151
+822% +$15.5M ﹤0.01% 3267
2021
Q2 		$2.22M Sell
49,507
-190,155
-79% -$8.81M ﹤0.01% 6337
2021
Q1 		$12M Buy
239,662
+226,079
+1,664% +$15.4M ﹤0.01% 2703
2020
Q4 		$1.21M Sell
13,583
-24,210
-64% -$2.04M ﹤0.01% 6387
2020
Q3 		$2.88M Buy
+37,793
New +$2.4M ﹤0.01% 4043

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's CELL Position: Q2 2023 in Review

Citadel Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 67,104 shares — an estimated $54.9K sold.

Citadel Advisors first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $12M in Q1 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Citadel Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 67,104 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $54.9K.
  • Citadel Advisors first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Citadel Advisors's PhenomeX Inc. Common Stock position peaked at $12M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.